EMvision Medical Devices Ltd (ASX: EMV) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

EMvision Medical Devices Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $163.57 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 92.94 million
Earnings per share -0.118
Dividend per share N/A
Year To Date Return -0.84%
Earnings Yield N/A
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • EMvision Medical Devices Ltd (ASX: EMV)
    Latest News

    Rising healthcare ASX share price represented by doctor giving thumbs up
    Share Market News

    Why the EMvision (ASX: EMV) share price closed 13% higher today

    The EMvision (ASX: EMV) share price finished 13% higher today after the company announced grant success. Here's the rundown.

    Read more »

    asx share price in trading halt represented by business man stopping falling row of dominoes
    Share Market News

    Why the EMvision (ASX:EMV) share price is going nowhere

    The EMvision (ASX:EMV) share price is unchanged today after the company announced a trading halt on Friday. We take a…

    Read more »

    Share Market News

    Here's why the EMvision (ASX:EMV) share price is up 9% this week

    The EMVision share price is up by almost 10% this week, after the company announced a cash injection and a…

    Read more »

    Falling ASX share price represented by business man wearing box on his head with a sad, crying face on it.
    Share Market News

    EMvision (ASX:EMV) share price falling despite positive results

    The EMvision share price is falling lower today despite the company announcing positive results in clinical trials of its stroke…

    Read more »

    EMV ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About EMvision Medical Devices Ltd

    EMvision Medical Devices Ltd is an Australian medical device company. The company is focused on the research and development, and commercialisation of neurodiagnostic technology for stroke diagnosis and monitoring, as well as other medicalimaging needs. Its focus is portable, cost-effective, and non-invasive brain scanners, including a bedside device (emu) and an ultra-lightweight pre-hospital device (First Responder). Its first indication targets acute stroke care, with a second planned indication in traumatic brain injury.

    EMV Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    02 Mar 2026 $1.76 $-0.01 -0.57% 31,291 $1.76 $1.77 $1.73
    27 Feb 2026 $1.77 $0.00 0.00% 22,783 $1.76 $1.77 $1.74
    26 Feb 2026 $1.76 $-0.01 -0.56% 11,815 $1.73 $1.76 $1.73
    25 Feb 2026 $1.78 $0.01 0.57% 66,183 $1.75 $1.78 $1.72
    24 Feb 2026 $1.76 $-0.01 -0.56% 43,809 $1.77 $1.77 $1.73
    23 Feb 2026 $1.78 $0.02 1.14% 25,651 $1.75 $1.78 $1.75
    20 Feb 2026 $1.75 $-0.02 -1.13% 19,142 $1.77 $1.78 $1.75
    19 Feb 2026 $1.78 $0.02 1.14% 5,500 $1.78 $1.80 $1.77
    18 Feb 2026 $1.75 $-0.01 -0.57% 13,659 $1.77 $1.78 $1.75
    17 Feb 2026 $1.76 $-0.02 -1.12% 2,881 $1.78 $1.78 $1.76
    16 Feb 2026 $1.78 $-0.02 -1.11% 27,530 $1.78 $1.78 $1.76
    13 Feb 2026 $1.80 $0.02 1.12% 18,504 $1.79 $1.80 $1.78
    12 Feb 2026 $1.79 $-0.02 -1.11% 37,022 $1.79 $1.80 $1.78
    11 Feb 2026 $1.80 $0.00 0.00% 22,745 $1.77 $1.80 $1.77
    10 Feb 2026 $1.80 $0.00 0.00% 49,876 $1.78 $1.81 $1.77
    09 Feb 2026 $1.81 $0.04 2.27% 21,310 $1.76 $1.81 $1.76
    06 Feb 2026 $1.76 $0.01 0.57% 14,809 $1.75 $1.76 $1.73
    05 Feb 2026 $1.75 $-0.06 -3.31% 46,921 $1.78 $1.79 $1.74
    04 Feb 2026 $1.81 $0.00 0.00% 6,672 $1.79 $1.82 $1.77
    03 Feb 2026 $1.81 $0.04 2.25% 38,425 $1.79 $1.84 $1.77

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    31 Dec 2025 Phillip Dubois Expiry 200,000 $356,000
    Options expired.
    31 Dec 2025 Anthony (Tony) Keane Expiry 200,000 $356,000
    Options expired.
    31 Dec 2025 John Keep Expiry 300,000 $534,000
    Options expired.
    31 Dec 2025 Scott Kirkland Expiry 500,000 $890,000
    Options expired.
    18 Nov 2025 Carmel Monaghan Issued 200,000 $358,000
    Issue of options.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Dr Phillip James Dubois Non-Executive Director Sep 2020
    Dr Dubois is nuclear imaging specialist, and former CEO of their imaging division and served as Executive Director. He is also the founder and former CEO and Chairman of Queensland X Ray. He is currently an Associate Professor of Radiology at the University of Queensland Medical School. He has served on numerous government and radiology group bodies, including the councils of the Royal Australian and New Zealand College of Radiologists and the Australian Medical Association, and as Vice President of the Australian Diagnostic Imaging Association. He is Chair of Clinical Advisory Board.
    Mr Anthony (Tony) Keane Non-Executive Director Jun 2018
    Mr Keane is an experienced business and finance executive and holds a number of independent non executive director and advisory board roles. He also undertakes finance advisory and consultancy assignments for various business clients and previously held numerous roles with a major trading bank principally in business, corporate and institutional banking. He is currently an Independent Non Executive Director and Chairman of National Storage Holdings Ltd, the holding company established for National Storage REIT, the first independent, internally managed and fully integrated owner and operator of self storage centres listed on the ASX. He is chair of the risk committee.
    Mr John Keep Non-Executive ChairmanNon-Executive Director Mar 2018
    Mr Keep has public company board and senior management experience in the healthcare and hospitality sectors including both medical diagnostic companies and start up enterprises. Previously Chief Executive of Queensland Diagnostic Imaging, one of Queenslands most successful radiology and diagnostic imaging groups and later as Director of Operations at Lemarne Healthcare, a company specializing in the diagnosis and treatment of skin cancer. He was previously Company Secretary of Castlemaine Tooheys Limited which had a market capitalization on the ASX of $1.2 Billion prior to its takeover. He is member of the risk committee.
    Mr Scott Kirkland Co-founderExecutive DirectorChief Executive OfficerManaging Director Jul 2017
    Mr Kirkland has held several senior sales and marketing positions, including Head of Client Sales at Quantcast, a US based AI technology company, prior to establishing EMVision as a leader in innovative neurodiagnostic technology.
    Mr Patryk Kania Non-Executive Director Mar 2024
    Mr Kania is a medical device executive with over 20 years of commercialisation and leadership experience in medical devices, pharma and health technologies working across the US, Europe and APAC, within sales and marketing management, and general management roles. Currently he is CEO and President USA of Field Orthopaedics Ltd. and has previously held senior roles at Smith Nephew, Abbott, J&J Medical and Roche. He is member of the risk committee.
    Ms Carmel Anne Monaghan Non-Executive Director Jun 2025
    Ms Monaghan is a healthcare leader. She has worked across hospital, corporate and global positions at Ramsay for almost three decades. Prior to her appointment as CEO of Ramsay Australia, she was the Group Chief of Staff of Ramsays global operations, gaining experience and a comprehensive understanding of health care operations and strategy both in Australia and overseas. She also served as the Group Head of Marketing and Public Affairs, driving marketing, brand and communications strategy, during which the group grew to become one of the leading private healthcare operators globally.
    Ms Emma Waldon Company Secretary
    -
    Emma Waldon Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Keysight Technologies Inc 7,454,231 8.72%
    Mr Scott Philip Kirkland 3,861,987 4.52%
    Mr Ryan Michael Laws 2,990,000 3.50%
    BNP Paribas Nominees Pty Ltd <Hub24 Custodial Serv Ltd> 2,436,671 2.85%
    Citicorp Nominees Pty Limited 1,829,038 2.14%
    Dr Ronald Peter Weinberger <Rpw A/C> 1,639,158 1.92%
    Mr Paul Raymond Brown & Mrs Angelique Susan Brown <Brown Family A/C> 1,490,000 1.74%
    J P Morgan Nominees Australia Pty Limited 1,301,694 1.52%
    Jm Starcevich Investments Pty Ltd 1,230,000 1.44%
    Uniquest Pty Limited 1,200,000 1.40%
    Busso Holdings Pty Ltd <Bew A/C> 1,160,000 1.36%
    Mr Vincent Michael O'Sullivan <O'Sullivan A/C> 1,155,000 1.35%
    Glensburg Pty Ltd <Tyto Corp Pension Fund A/C> 1,112,000 1.30%
    Walsh Prestige Pty Ltd <Walsh Family A/C> 1,050,000 1.23%
    Dr Stuart Crozier 1,044,937 1.22%
    Mr Martin Kolev 1,000,000 1.17%
    Bowling Family Holdings Pty Ltd <Bowling Family S/F A/C> 868,503 1.02%
    BNP Paribas Nominees Pty Ltd <IB AU Noms Retailclient> 811,660 0.95%
    Mr Kong Pak Lim 810,500 0.95%
    Mr Aron Wakil 797,519 0.91%

    Profile

    since

    Note